作者：
Anthos,Christofides [1]
;
Xanthi-Lida,Katopodi [2]
;
Carol,Cao [3]
;
Dimitra,Karagkouni [4]
;
Konstantinos,Aliazis [5]
;
Sasitorn,Yenyuwadee [6]
;
Halil-Ibrahim,Aksoylar [7]
;
Rinku,Pal [1]
;
Mohamed A A,Mahmoud [2]
;
Laura,Strauss [8]
;
Natalia M,Tijaro-Ovalle [5]
;
Louis,Boon [6]
;
John,Asara [7]
;
Ioannis S,Vlachos [1]
;
Nikolaos,Patsoukis [2]
;
Vassiliki A,Boussiotis [3]
作者单位：
Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
[1]
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
[2]
Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA.
[3]
Department of Medicine, Yale University, New Haven, CT, USA.
[4]
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
[5]
Harvard Medical School Initiative for RNA Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
[6]
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
[7]
Harvard College, Cambridge, MA, USA.
[8]
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
[9]
Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[10]
Sanofi /Tidal, Cambridge, MA, USA.
[11]
JJP Biologics, Warsaw, Poland.
[12]
Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA.
[13]
Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. vboussio@bidmc.harvard.edu.
[14]
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. vboussio@bidmc.harvard.edu.
[15]
Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA. vboussio@bidmc.harvard.edu.
[16]
DOI
10.1038/s41590-022-01385-x
PMID
36581713
发布时间
2024-07-12
换一批
换一批
